SCHEMBL6695348

SCHEMBL6695348

O=C(CCCCCCCCC(=O)OCC1CC2CCC1C2)OCC1CC2CCC1C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
LPAR1 Q92633 3/20 0.39
LPAR3 Q9UBY5 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
EPHX2 P34913 2/20 0.37
TDP1 Q9NUW8 2/20 0.36
SIRT5 Q9NXA8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
ENPP2 Q13822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6694096 0.98 ALDH1A1 (0.40) ALDH1A1LPAR1LPAR3MEN1KMT2A
SCHEMBL6697213 0.95 LMNA (0.42) ALDH1A1LPAR1LPAR3MEN1KMT2A
SCHEMBL6697793 0.91 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL32688856 0.89 ALDH1A1 (0.42) ALDH1A1LPAR1LPAR3EPHX2ENPP2
SCHEMBL32688733 0.85 ALDH1A1 (0.44) ALDH1A1LPAR1LPAR3MEN1KMT2A
SCHEMBL6697591 0.84 MEN1 (0.45) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL10358420 0.81 MEN1 (0.41) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL9810566 0.80 MEN1 (0.42) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL31716524 0.79 MEN1 (0.42) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL13277673 0.79 MEN1 (0.42) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040210081-A1 Carboxylic esters based on 2-hydroxymethylnorbornane CELANESE CHEMICALS EUROPE GMBH (DE) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040210081-A1 Carboxylic esters based on 2-hydroxymethylnorbornane TAF1, HSD17B10, SULT1E1 ALDH1A1 182/4885LPAR1 3563/4885LPAR3 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.